Camber Pharmaceuticals Launches Generic Concerta®

Piscataway, NJ, September 5, 2019– Camber Pharmaceuticals is pleased to announce the addition of Methylphenidate ER Tablets to our growing portfolio of products.
Methylphenidate ER tablets are the generic version of Concerta®. Methylphenidate is used to treat attention-deficit hyperactivity disorder (ADHD). Methylphenidate ER tablets are available in a 18, 27, 36 and 54 mg- 100ct bottles.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection